Introduction:

Complications associated with the placement procedure of a septal occlusion device occur in less than 10% of cases. Embolization requires cardiac surgery, which increases the risk of mortality.

Objective:

To report the case of a patient with ventricular septal defect and severe pulmonary hypertension who had the transcatheter septal occlusion device removed.

Case report:

We report the case report of a 24-year-old woman with ventricular septal defect, heart failure (New York Heart Association) class IV and type 2 pulmonary hypertension. She was scheduled for placement of a septal occlusion device, however, the placement of the device failed and had a residual defect of 7 mm, so the placement was removed 48 hours later without complications.

Conclusions:

Although transcatheter closure of the ventricular septal defect is a safe and effective alternative to surgery, it is not free of complications. In case of translocation of the septal occlusion device, it must be removed during the same procedure, since the risk of embolization is high and if it occurs, the risk of death increases.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )